Invasion of Human Skin Fibroblasts by the Lyme Disease Spirochete, Borrelia burgdorferi
Abstract
The ability of Borrelia burgdorferi to attach to and invade human fibroblasts was investigated by scanning electron and confocal microscopy. By scanning electron microscopy, B. burgdorferi were tightly adherent to fibroblast monolayers after 24-48 h but were eliminated from the cell surface by treatment with ceftriaxone (1 microgram/mL) for 5 days. Despite the absence of visible spirochetes on the cell surface after antibiotic treatment, viable B. burgdorferi were isolated from lysates of the fibroblast monolayers. B. burgdorferi were observed in the perinuclear region within human fibroblasts by laser scanning confocal microscopy. Intracellular spirochetes specifically labeled with monoclonal anti-flagellin antibody were also identified by fluorescent laser scanning confocal microscopy. These observations suggest that B. burgdorferi can adhere to, penetrate, and invade human fibroblasts in organisms that remain viable.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Key Biomarkers
Symptom Clusters
Cited By (5)
- Borrelia burgdorferiInduces TLR1 and TLR2 in Human Microglia and Peripheral Blood Monocytes but Differentially Regulates HLA-Class II ExpressionJournal of Neuropathology & Experimental Neurology · 2006
- Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme diseaseClinical Infectious Diseases · 2007
- Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated CoinfectionsMicroorganisms · 2023
- Ultrastructural demonstration of spirochetal antigens in synovial fluid and synovial membrane in chronic lyme disease: Possible factors contributing to persistence of organismsHuman Pathology · 1996
- Lyme borreliosis: basic science and clinical aspectsThe Lancet · 1994
References (3)
- Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosisInfection · 1989
- Lyme disease: recommendations for diagnosis and treatmentAnnals of Internal Medicine · 1991
- Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitroThe Journal of Infectious Diseases · 1992
Related Papers
- Fibronectin binding protein BBK32 of the lyme disease spirochete promotes bacterial attachment to glycosaminoglycansInfection and Immunity · 2006 · 4 shared tags
- Recombinant immunoblot in the serodiagnosis of Lyme borreliosisMedical Microbiology and Immunology · 1993 · 4 shared tags
- Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu latoResearch in Microbiology · 1995 · 4 shared tags
- Clinical Pathologic Correlations of Lyme DiseaseClinical Infectious Diseases · 1988 · 4 shared tags
- Clinical manifestations of Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg (A) 1986 Dec; 2631(1-2):201-51986 · 4 shared tags
- An epidemiologic study of Lyme disease in southern SwedenNew England Journal of Medicine · 1995 · 4 shared tags